Joel Greenblatt’s Ocugen OCGN Stock Holding History

Joel Greenblatt’s Portfolio OCGN Stock Details OCGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-11,940	Closed	-$81K	–	1079
2021 Q1	$81K	Buy	+11,940	New	+$79.4K	﹤0.01%	974

Other funds holding OCGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

VCM

Valiant Capital Management San Francisco, California $2.48B AUM 57.08% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

Joel Greenblatt's OCGN Position: Q2 2021 in Review

Joel Greenblatt sold out of Ocugen (OCGN) in Q2 2021, closing a stake of 11,940 shares — an estimated $81K sold.

Joel Greenblatt first reported a position in OCGN in Q1 2021 and held it in 1 quarter. The position peaked at $81K in Q1 2021. 129 funds tracked by Wall St. Rank hold OCGN as of Q2 2021.

Joel Greenblatt reported no remaining Ocugen position as of Q2 2021 after selling out during the quarter.
Joel Greenblatt sold 11,940 Ocugen shares in Q2 2021, an estimated $81K.
Joel Greenblatt first reported a position in Ocugen in Q1 2021 and held it in 1 quarter.
Joel Greenblatt's Ocugen position peaked at $81K in Q1 2021.
129 funds tracked by Wall St. Rank held Ocugen as of Q2 2021.

Based on Gotham Asset Management's 13F filing for Q2 2021, filed 16 Aug 2021.